What is the main reason for this 8-K filing?

This 8-K filing is primarily to inform investors that the United States Department of Justice has filed a complaint against Walmart regarding its role in the dispensing and distribution of opioids.

What is Walmart's position on the DOJ complaint?

Walmart has issued a corporate statement in response to the DOJ's complaint, which is furnished as an exhibit to this 8-K. Investors should refer to Exhibit 99.1 for the company's official statement.

Does this filing have implications for Walmart's financial statements or reporting?

This specific 8-K filing is for regulatory disclosure of a legal event and includes a corporate statement. The information furnished is not deemed 'filed' for purposes of Section 18 of the Exchange Act and generally will not be incorporated into other SEC filings unless specifically referenced. However, the underlying legal matter could have future financial implications that would be disclosed in subsequent filings if material.

What are the potential financial consequences for Walmart?

This 8-K does not detail potential financial consequences. The filing acknowledges the DOJ's complaint. Any material financial impact stemming from this legal action would likely be disclosed in future SEC filings (e.g., 10-Q, 10-K) as developments occur or if a resolution is reached.

WMT 8-K: Regulation FD — Dec 22, 2020

Summary

Walmart Inc. (WMT) filed an 8-K on December 22, 2020, to disclose that the United States Department of Justice (DOJ) had filed a complaint against the company concerning its role in the dispensing and distribution of opioids. This filing primarily serves as a notification of the legal action and includes a corporate statement from Walmart addressing the DOJ's complaint. Investors should note that this information is furnished under Regulation FD and is not deemed 'filed' for purposes of liability under Section 18 of the Exchange Act, nor incorporated by reference into other SEC filings unless specifically stated.

Key Highlights

1Walmart Inc. is the subject of a complaint filed by the United States Department of Justice.
2The DOJ complaint pertains to Walmart's dispensing and distribution of opioids.
3The company has issued a corporate statement in response to the DOJ's legal action.
4The 8-K filing includes this corporate statement as Exhibit 99.1.
5This disclosure is made under Regulation FD and is not considered 'filed' for Section 18 liability.
6The information furnished is not incorporated by reference into other SEC filings unless expressly noted.

Walmart Inc. 8-K Report, Regulation FD Disclosure (Dec 22, 2020)

Summary

Key Highlights

Frequently Asked Questions